GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Q

Quick-Med Technologies QMDT · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2013

Revenue

$928,493

FY2013FY2013

Net income

−$713,073

FY2013FY2013

Free cash flow

−$824

FY2013FY2013

Shareholders' equity

−$9.1m

FY2013FY2013

Income statement

Fiscal years

FY2013
Revenue$928,493
Gross profit$647,988
Research and development$519,836
Operating income−$376,075
Net income−$713,073
Diluted earnings per share-0.02

Balance sheet

At each fiscal year end

FY2013
Total assets$723,243
Cash and short-term investments$49,677
Total liabilities$9.8m
Debt$254,891
Shareholders' equity−$9.1m
Shares outstanding37m

Cash flow

Fiscal years

FY2013
Cash from operations$62,948
Capital spending−$63,772
Free cash flow−$824

Latest quarters

By quarter end

Jun 2013Mar 2013Dec 2012Sept 2012Jun 2012Mar 2012Dec 2011Sept 2011
Revenue$203,582$262,005$157,650$305,255$280,237$198,300$195,270$323,690
Gross profit$135,294$201,787$73,044$238,115$202,317$129,619$93,730$245,953
Operating income−$156,781$193,397−$236,282−$176,410−$232,709−$307,085−$404,157−$294,373
Net income−$160,063$84,676−$348,756−$288,930−$344,508−$418,846−$516,936−$406,613
Diluted earnings per share-0.000.00-0.01-0.01-0.01-0.01-0.01-0.01
Total assets$723,243$855,251$1.0m$1.4m$611,850$621,785$1.0m$1.3m
Cash and short-term investments$49,677$151,833$458,852$735,536$80,502$21,548$263,655$704,559
Debt$7.9m$267,527$319,891$7.6m$7.7m$7.1m$7.0m$6.9m
Shareholders' equity−$9.1m−$8.9m−$8.7m−$8.4m−$8.1m−$7.7m−$7.3m−$6.8m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-2.2%-7.4%—
Operating income-43.5%-29.9%-19.3%
Net income-41.4%-21.5%-16.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin68.5%68.7%75.4%—
Operating margin-83.8%-145.2%-154.0%—
Net margin-124.6%-208.4%-200.2%—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%-17%-74%89978%374108%70%-19%3194%105%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.